Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors

International Urology and Nephrology

Volumn 34, Issue 4, 2002, Pages 447-451

  Costa Bauzá, Antonia ^a   Barceló, Catalina ^a   Perelló, Juan ^a   Grases, Felix ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Brushite; Crystallization inhibitors; Hydroxyapatite; Nucleation; Phytate; Pyrophosphate; Synergy

Indexed keywords

CALCIUM ION; CALCIUM PHOSPHATE DIBASIC; CITRATE SODIUM; CITRIC ACID; CRYSTALLIZATION INHIBITOR; HYDROXYAPATITE; PHYTATE; PYROPHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); CRYSTALLIZATION; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; HUMAN; KINETICS; MOLECULAR WEIGHT; TURBIDIMETRY; URINE;

CALCIUM PHOSPHATES; CITRATES; CRYSTALLIZATION; DIPHOSPHATES; DRUG SYNERGISM; DURAPATITE; HUMANS; KIDNEY CALCULI; MOLECULAR WEIGHT; PHYTIC ACID;

EID: 0141991751     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025671019653     Document Type: Article

References (17)

1. Fleisch H, Bisaz S. Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol 1962; 203: 671.
2. Grases F, Masárová L, Söhnel O, Costa-Bauzá A. Agglomeration of calcium oxalate monohydrate in synthetic urine. Brit J Urol 1992; 70: 240.
3. Grases F, García-Ferragut L, Costa-Bauzá A. Study of the early stages of renal stone formation: Experimental model using urothelium of pig urinary bladder. Urol Res 1996; 24: 305.
4. Grases F, García-Ferragut L, Costa-Bauzá A, March JG. Study of the effects of different substances on the early stages of papillary stone formation. Nephron 1996; 73: 561.
5. Grases F, Söhnel O, Villacampa AI, March JG. Phosphates precipitating from artificial urine and fine structure of phosphate renal calculi. Clin Chim Acta 1996; 244: 45.
6. Grases F, Costa-Bauzá A, Königsberger E, Königsberger L-C. Kinetic versus thermodynamic factors in calcium renal lithiasis. Int Urol Nephrol 2000; 32: 19.
7. Hess B. The role of Tamm-Horsfall glycoprotein and nephrocalcin in calcium oxalate monohydrate crystallization processes. Scanning Microsc 1991; 5: 689.
8. Hess B. Tamm-Horsfall glycoprotein-inhibitor or promoter of calcium oxalate monohydrate crystallization processes? Urol Res 1992; 20: 83.
9. Hoyer JR. Uropontin in urinary calcium stone formation. Miner Electrolyte Metab 1995; 20: 385.
10. Meyer JL, Smith LH. Growth of calcium oxalate crystals. II. Inhibition by natural crystal growth inhibitors. Invest Urol 1975; 13: 36.
11. Nakagawa Y, Abram V, Coe FL. Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine. Am J Physiol 1984; 247: F765.
12. Pak CYC. Citrate and renal calculi. Miner Electrolyte Metab 1987; 13: 257.
13. Ryall RL, Harnett RM, Marshal VR. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 1981; 112: 349.
14. Scurr DS, Robertson WG. Modifiers of calcium oxalate crystallization found in urine III. Studies on the role of Tamm Horsfall mucoprotein and of ionic stregth. J Urol 1986; 136: 505.
15. See WA, Williams RD. Urothelial injury and clotting cascade activation: Common denominators in particulate adherence to urothelial surfaces. J Urol 1992; 147: 541.
16. Shum DK, Gohel MD. Separate effects of urinary chondroitin sulphate and heparan sulphate upon the crystallization of urinary calcium oxalate: Differences between stone formers and normal controls. Clin Sci 1993; 85: 33.
17. Worcester EM, Nakagawa Y, Coe FL. Glycoprotein calcium oxalate crystal growth inhibitor in urine. Miner Electrolyte Metab 1987; 13: 267.